DBI — Deutsche Biotech Innovativ AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Deutsche Biotech Innovativ AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	GAS	GAS	GAS	GAS	GAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0.002	0	0	0
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.197	0.113	1.02	0.901	-0.059
Operating Profit	-0.197	-0.11	-1.02	-0.901	0.059
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-0.223	-0.236	-1.09	-0.993	-0.037
Net Income After Taxes	-0.223	-0.236	-1.09	-0.993	-0.037
Net Income Before Extraordinary Items
Net Income	-0.223	-0.236	-1.09	-0.993	-0.037
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.223	-0.236	-1.09	-0.993	-0.037
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.236	-0.25	-1.15	-0.133	-0.147
Dividends per Share